or Try an Advanced Search...

    ETF Components for LABU - Direxion Daily S&P Biotech Bull 3X Shares


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    INCY C 1.89 2.06
    NTRA B -1.24 2.02
    UTHR C 1.51 1.92
    GILD C 0.48 1.88
    NBIX C 0.52 1.70
    VRTX F 0.13 1.68
    ALNY D -0.77 1.64
    INSM C -0.89 1.61
    AMGN D 1.60 1.50
    SRPT D 3.38 1.48
    ABBV D 3.04 1.47
    BIIB F -0.07 1.42
    MDGL B 5.53 1.35
    VKTX F 1.86 1.35
    EXAS D -0.30 1.31
    BMRN D 1.28 1.30
    CYTK F 3.00 1.17
    REGN F -0.87 1.14
    BPMC C -2.56 1.12
    TGTX B 1.51 1.05
    HALO F 7.22 1.00
    CRSP D 3.43 1.00
    RNA D 1.62 0.99
    MRNA F 7.48 0.98
    RVMD C -0.05 0.96
    KRYS B 4.45 0.81
    ADMA B -0.56 0.79
    EXEL B 2.24 0.77
    ROIV C 6.01 0.76
    IONS F 0.21 0.74
    ALKS B 3.90 0.72
    PCVX D 0.17 0.60
    CRNX C -1.70 0.58
    BBIO F 0.77 0.58
    APLS D 10.88 0.57
    IOVA F 3.76 0.56
    TWST D 1.37 0.54
    GERN D 1.24 0.53
    ACLX C 3.69 0.53
    DYN F -0.13 0.50
    SWTX C 7.49 0.50
    BEAM D 6.23 0.49
    AGIO C 0.25 0.49
    ACAD D 1.17 0.48
    RXRX F -0.87 0.47
    RARE D 2.65 0.47
    IMVT F 1.24 0.43
    PTCT B 0.79 0.43
    FOLD F 1.68 0.41
    VERA B 2.72 0.39
    MIRM B 2.87 0.39
    ARWR F 1.42 0.38
    RYTM C 1.54 0.38
    NUVL D 2.37 0.38
    NTLA F 3.62 0.38
    PTGX C 11.55 0.37
    IDYA F 0.71 0.37
    DVAX C 0.49 0.35
    DNLI D 1.94 0.33
    VCYT B 1.67 0.33
    JANX C 8.19 0.33
    SRRK B 12.19 0.32
    KYMR D 3.38 0.30
    SNDX F 3.14 0.29
    BCRX D 1.47 0.28
    CGON F 3.49 0.28
    ARDX F 3.71 0.28
    VCEL B 4.23 0.28
    AKRO B 4.90 0.27
    NVAX F 5.35 0.27
    ARQT C -0.98 0.27
    CPRX C 1.70 0.26
    KROS D 3.86 0.25
    NRIX D -1.43 0.25
    CLDX F 3.05 0.23
    MNKD C -0.87 0.22
    IRON B 2.29 0.22
    SMMT D 3.15 0.21
    VRDN D 2.96 0.20
    RCKT F 10.32 0.19
    DAWN F 2.85 0.19
    TVTX B -0.05 0.17
    MYGN F 2.45 0.17
    CGEM F 2.62 0.17
    IRWD F 2.99 0.16
    CDNA D 2.44 0.15
    VIR D 2.45 0.15
    XNCR B 3.78 0.15
    KURA F 7.36 0.15
    CDMO B 0.41 0.14
    APLT B 3.83 0.14
    ALT C 3.27 0.13
    RCUS F 2.94 0.13
    EBS C 0.85 0.13
    HUMA F 2.51 0.12
    ARCT F -0.94 0.12
    COGT D 1.67 0.11
    ETNB C 4.53 0.11
    ANNX F -0.58 0.11
    AVXL B 1.00 0.11
    VERV F 5.43 0.11
    SPRY D 4.63 0.11
    STOK F 1.42 0.11
    REPL B 35.11 0.11
    IMNM F 4.25 0.10
    PRTA F 1.11 0.10
    RLAY F 2.37 0.10
    MDXG B -0.22 0.10
    RGNX F 4.47 0.09
    OLMA F 11.56 0.09
    ALLO F 4.74 0.08
    ANAB F 5.20 0.08
    OCGN F 0.72 0.08
    CELC F 3.61 0.08
    SAGE F 6.60 0.08
    SANA F 11.06 0.08
    ERAS C 3.85 0.07
    CCCC F 5.99 0.07
    FDMT F -2.50 0.07
    ORIC F 5.15 0.06
    SCLX F -5.57 0.05
    SVRA D 3.70 0.05
    ALEC F 4.79 0.04
    YMAB F 3.07 0.04
    ABUS D 1.45 0.04
    ITOS F 2.34 0.04
    KALV D 8.85 0.04
    FATE F 10.63 0.04

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Medicine Immunology Organ Systems Biology Disease Immune System Solid Tumors Clinical Development Antibodies Monoclonal Antibody Monoclonal Antibodies Enzymes Infectious Diseases Autoimmune Disease Treatment Of Cancer
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Drug Manufacturers - General Medical Devices

    Recent News for Direxion Daily S&P Biotech Bull 3X Shares & its Holdings

    Date Stock Title
    Nov 23 BBIO Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
    Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
    Nov 22 IMNM Immunome files to sell 1.80M shares of common stocks by selling shareholders
    Nov 22 REPL S&P 500 Moves Higher; Intuit Shares Fall Following Q1 Results
    Nov 22 MRNA Jefferies says market nears short term “peak RFK negativity", Vaccine makers up
    Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
    Nov 22 MRNA Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock
    Nov 22 XNCR Xencor: Plamotamab NHL Data Leads To RA Program Advancement
    Nov 22 MRNA Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference
    Nov 22 SRPT High Growth Tech Stocks to Watch in November 2024
    Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
    Nov 22 MRNA Moderna up 8% as Jefferies says market is close to 'peak RFK negativity'
    Nov 22 HALO Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
    Nov 22 HALO Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why
    Nov 22 VKTX Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?
    Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
    Nov 22 REPL Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug
    Nov 22 MRNA Moderna's Fresh Blow As RFK Heads To HHS - A Tough 2025 May Be In Store
    Nov 22 ABBV AbbVie upgraded to outperform by Leerink on recent sell-off
    Nov 22 VKTX Viking Therapeutics a new buy at B Riley on lead obesity asset VK2735
    The investment seeks daily investment results, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The index is provided by S&P and includes domestic companies from the biotechnology industry. The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. These financial instruments include: swap agreements; options on securities and indices; forward contracts; reverse repurchase agreements; ETFs; and other financial instruments. The fund is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Index Fund Biotechnology Leveraged ETF Ultra ETF S&P 500 Index CBOE Repurchase Agreement Forward Contract
    Back to the Main LABU Page...